Silence Therapeutics : Condensed consolidated income stateme

Condensed consolidated income statement









Three months ended




...

Related Keywords

United Kingdom , United States , Hong Kong , London , City Of , Macau , Taiwan , Redmile , Leicestershire , China , Berlin , Germany , New Jersey , German , American , , International Financial Reporting Standards , European Union , Astrazeneca , International Accounting Standard , Frazier Life Sciences , Uk Parliament , Redmile Group , Research Collaboration , Journal Of The American Medical Association , Public Company Accounting Oversight Board , International Accounting Standards Board , Alnylam Pharmaceuticals Inc , Company Or Silence , Company American Depositary Shares Adss , Group London , Securities Exchange , Program Updates , Implications Of Being An Emerging Growth Company , Exchange Commission , National Insurance Contributions , Growth Company , Cache Holdings , Registrar Of Companies , American Society Of Hematology , Hansoh Pharmaceutical Group Company Limited , Nextech Invest Ltd , Companies Act , Interim Financial Reporting , Critical Accounting Policies , American Depositary Shares , Private Placement , Logos Capital , Astrazeneca Collaboration , Alnylam Pharmaceuticals , Chief Executive Officer , Open Market Sale Agreement , Sales Agreement , Securities Act , Annual Report , Oligonucleotide Discovery , American Society , American Journal , Recent Business Highlights , Proprietary Program Updates , American Medical Association , Partnered Program Updates , Cache Holdings Limited , China Region , Greater China , Development Costs , Nasdaq Stock Market , From April , Finance Bill , Added Tax , Income Statements , Administrative Expenses , Qualitative Disclosures , Market Risk , Liquidity Risk , Accounting Policies , Collaboration Agreements , License Agreement , Clinical Trial Expenses , Silence Therapeutics , Emerging Growth Company , Foreign Private Issuer , Jumpstart Our Business Startups Act , Sarbanes Oxley Act , Securities Exchange Act , Exchange Act , Capital Resources , Capital Expenditure Requirements ,